Transform Your Endotoxin Testing with ENDOLISA®
At bioMérieux, we understand the unique challenges you face in endotoxin testing for cell and gene therapies, which is why we’ve developed a solution that directly addresses them. By integrating ENDOLISA® with the ASSIST PLUS system, we’ve automated the most critical steps of the assay. This integration enhances the precision of the washing process and the consistency of the results.
Why ENDOLISA® for Cell & Gene Therapies?
- Expertise in Complex Biological Matrices
Our innovative solutions are designed to effectively handle sophisticated compositions, including viral vectors and living cells. ENDOLISA®’s advanced methodologies enable reliable endotoxin testing, empowering you to navigate complex environments with confidence. - Simple Workflows for Accurate Results
With our user-friendly processes, you can achieve rapid, accurate results with minimal hands-on time. This simplicity allows for decentralized lab testing, bringing it closer to your manufacturing suite and reducing the need for extensive training and expertise. - Comprehensive Regulatory Support
As regulatory landscapes evolve, ENDOLISA® stays ahead by offering full validation support and access to technical expertise. Our team helps you to meet new regulations seamlessly, particularly for advanced cell therapies with short shelf lives, giving you peace of mind every step of the way.
Ready to Upgrade your Endotoxin Testing with ENDOLISA® for Cell & Gene Therapies?
Contact our experts today for more information on ENDOLISA®.